Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Softgel Technologies
  6.  » Advancing Lipid-Based Formulations and Softgels in Drug Development

Advancing Lipid-Based Formulations and Softgels in Drug Development

Summary: This executive summary highlights lipid-based formulations (LBFs) in pharmaceutical development, emphasizing their complex composition and the critical role of careful formulation selection in the early stages of drug development. Early incorporation of LBFs allows adaptability and scalability throughout drug development. Softgel encapsulation of LBFs is highly regarded for its dosing convenience, controlled release, and improved compliance. Additionally, they are versatile and suitable for diverse routes of administration and for use with challenging Active Pharmaceutical Ingredients. Contrary to common perceptions, LBFs and softgels are more cost-effective solution compared to other bioavailability-enhancing technologies, offering seamless scalability.

Click here to download the executive summary